Atlas Trials

Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

RecordFirmDate
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies (NCT03272633)Rutgers, The State University of New Jersey2020-10-26
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998)City of Hope Medical Center2019-02-04
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma (NCT03534180)City of Hope Medical Center2018-08-21
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782)M.D. Anderson Cancer Center2017-11-14
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625)National Cancer Institute (NCI)2017-09-27
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas (NCT01897012)National Cancer Institute (NCI)2013-07-17
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533)National Cancer Institute (NCI)2012-08-03
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant (NCT01431209)University of Nebraska2011-08-12

Track Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.